Table of Contents

2019-2024 Global Pemetrexed Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Pemetrexed Consumption 2014-2024
  • 2.1.2 Pemetrexed Consumption CAGR by Region
• 2.2 Pemetrexed Segment by Type
  • 2.2.1 100mg
  • 2.2.2 500mg
• 2.3 Pemetrexed Consumption by Type
  • 2.3.1 Global Pemetrexed Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Pemetrexed Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Pemetrexed Sale Price by Type (2014-2019)
• 2.4 Pemetrexed Segment by Application
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Retail Pharmacies
  • 2.4.3 Online Pharmacies
• 2.5 Pemetrexed Consumption by Application
  • 2.5.1 Global Pemetrexed Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Pemetrexed Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Pemetrexed Sale Price by Application (2014-2019)

3 Global Pemetrexed by Players

• 3.1 Global Pemetrexed Sales Market Share by Players
  • 3.1.1 Global Pemetrexed Sales by Players (2017-2019)
  • 3.1.2 Global Pemetrexed Sales Market Share by Players (2017-2019)
• 3.2 Global Pemetrexed Revenue Market Share by Players
  • 3.2.1 Global Pemetrexed Revenue by Players (2017-2019)
  • 3.2.2 Global Pemetrexed Revenue Market Share by Players (2017-2019)
• 3.3 Global Pemetrexed Sale Price by Players
• 3.4 Global Pemetrexed Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Pemetrexed Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Pemetrexed Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Pemetrexed by Regions

• 4.1 Pemetrexed by Regions
  • 4.1.1 Global Pemetrexed Consumption by Regions
  • 4.1.2 Global Pemetrexed Value by Regions
• 4.2 Americas Pemetrexed Consumption Growth
• 4.3 APAC Pemetrexed Consumption Growth
• 4.4 Europe Pemetrexed Consumption Growth
• 4.5 Middle East & Africa Pemetrexed Consumption Growth

5 Americas

• 5.1 Americas Pemetrexed Consumption by Countries
  • 5.1.1 Americas Pemetrexed Consumption by Countries (2014-2019)
  • 5.1.2 Americas Pemetrexed Value by Countries (2014-2019)
• 5.2 Americas Pemetrexed Consumption by Type
• 5.3 Americas Pemetrexed Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Pemetrexed Consumption by Countries
  • 6.1.1 APAC Pemetrexed Consumption by Countries (2014-2019)
  • 6.1.2 APAC Pemetrexed Value by Countries (2014-2019)
• 6.2 APAC Pemetrexed Consumption by Type
• 6.3 APAC Pemetrexed Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Pemetrexed by Countries
  • 7.1.1 Europe Pemetrexed Consumption by Countries (2014-2019)
  • 7.1.2 Europe Pemetrexed Value by Countries (2014-2019)
• 7.2 Europe Pemetrexed Consumption by Type
• 7.3 Europe Pemetrexed Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Pemetrexed by Countries
  • 8.1.1 Middle East & Africa Pemetrexed Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Pemetrexed Value by Countries (2014-2019)
• 8.2 Middle East & Africa Pemetrexed Consumption by Type
• 8.3 Middle East & Africa Pemetrexed Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Pemetrexed Distributors
• 10.3 Pemetrexed Customer

11 Global Pemetrexed Market Forecast

• 11.1 Global Pemetrexed Consumption Forecast (2019-2024)
• 11.2 Global Pemetrexed Forecast by Regions
  • 11.2.1 Global Pemetrexed Forecast by Regions (2019-2024)
  • 11.2.2 Global Pemetrexed Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Pemetrexed Forecast by Type
• 11.8 Global Pemetrexed Forecast by Application

12 Key Players Analysis

• 12.1 Eli Lilly
  • 12.1.1 Company Details
  • 12.1.2 Pemetrexed Product Offered
  • 12.1.3 Eli Lilly Pemetrexed Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Eli Lilly News
• 12.2 Abbott Laboratories
  • 12.2.1 Company Details
  • 12.2.2 Pemetrexed Product Offered
  • 12.2.3 Abbott Laboratories Pemetrexed Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Abbott Laboratories News
• 12.3 Cadila Healthcare
  • 12.3.1 Company Details
  • 12.3.2 Pemetrexed Product Offered
  • 12.3.3 Cadila Healthcare Pemetrexed Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Cadila Healthcare News
• 12.4 Eagle Pharmaceuticals
  • 12.4.1 Company Details
  • 12.4.2 Pemetrexed Product Offered
  • 12.4.3 Eagle Pharmaceuticals Pemetrexed Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Eagle Pharmaceuticals News
• 12.5 Stada Arzneimittel
  • 12.5.1 Company Details
  • 12.5.2 Pemetrexed Product Offered
  • 12.5.3 Stada Arzneimittel Pemetrexed Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Stada Arzneimittel News

...

13 Research Findings and Conclusion

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

According to this study, over the next five years the Pemetrexed market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pemetrexed business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pemetrexed market by product type, application, key manufacturers and key regions and countries.

This study considers the Pemetrexed value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
100mg
500mg
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Eli Lilly
Abbott Laboratories
Cadila Healthcare
Eagle Pharmaceuticals
Stada Arzneimittel
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pemetrexed consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pemetrexed market by identifying its various subsegments.
Focuses on the key global Pemetrexed manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pemetrexed with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pemetrexed submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.